tirzepatide neuroprotection diabetesresearch #neuroprotection #tirzepatide Megan North MSN, APRN, NP-C

Not when fractions of a milliliter separate a therapeutic dose from a problematic one

Maternal obesity increases the risk for congenital malformations, including neural tube defects, cardiac malformations, oral clefts, and limb reduction defects

Besides, hypertension, hyperlipidemia, cardiovascular disease, COPD, gastroesophageal reflux disease, somnolence, and stroke are not significant

First time self-injecting

Jessie DPC Member who inspired the Body Program, after taking GLP-1 medication Alex DPC Member after taking GLP-1 medication Introducing Tirzepatide, the game-changing active pharmaceutical ingredient driving the success of Mounjaro and Zepbound*, empowering thousands to achieve and sustain weight loss through diligent diet and exercise

Venlafaxine Multiple dosing of topiramate (150 mg/day) in healthy volunteers did not affect the pharmacokinetics of venlafaxine or O-desmethyl venlafaxine